Gabrielle E. Callander

828 total citations · 1 hit paper
10 papers, 652 citations indexed

About

Gabrielle E. Callander is a scholar working on Public Health, Environmental and Occupational Health, Occupational Therapy and Endocrine and Autonomic Systems. According to data from OpenAlex, Gabrielle E. Callander has authored 10 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 3 papers in Occupational Therapy and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in Gabrielle E. Callander's work include Pregnancy-related medical research (8 papers), Occupational Health and Performance (3 papers) and Sleep and Wakefulness Research (2 papers). Gabrielle E. Callander is often cited by papers focused on Pregnancy-related medical research (8 papers), Occupational Health and Performance (3 papers) and Sleep and Wakefulness Research (2 papers). Gabrielle E. Callander collaborates with scholars based in Australia, Switzerland and Germany. Gabrielle E. Callander's co-authors include Ross A. D. Bathgate, Martina Kočan, Emma T. van der Westhuizen, Roger J. Summers, Michelle L. Halls, Walter G. Thomas, Laura H. Jacobson, Daniël Hoyer, Despina E. Ganella and Sherie Ma and has published in prestigious journals such as Physiological Reviews, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Gabrielle E. Callander

10 papers receiving 643 citations

Hit Papers

Relaxin Family Peptides and Their Receptors 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabrielle E. Callander Australia 8 466 69 65 59 50 10 652
Paulo Ribeiro Nóbrega Brazil 12 47 0.1× 36 0.5× 60 0.9× 82 1.4× 85 1.7× 62 414
P.-J. Shen Australia 7 247 0.5× 35 0.5× 22 0.3× 7 0.1× 26 0.5× 9 349
P Tapie France 10 79 0.2× 64 0.9× 107 1.6× 54 0.9× 11 0.2× 18 300
S. Gangooly United Kingdom 4 125 0.3× 19 0.3× 12 0.2× 23 0.4× 30 0.6× 5 342
Noa Regev Israel 9 56 0.1× 129 1.9× 34 0.5× 27 0.5× 135 2.7× 12 440
Helen Mok Singapore 10 321 0.7× 13 0.2× 16 0.2× 38 0.6× 124 2.5× 19 540
Sanae Tanaka Japan 12 35 0.1× 111 1.6× 13 0.2× 11 0.2× 46 0.9× 49 404
Andréa Z Pereira Brazil 15 72 0.2× 13 0.2× 150 2.3× 16 0.3× 256 5.1× 46 794
Robert J. T. Joy United States 13 36 0.1× 28 0.4× 9 0.1× 17 0.3× 22 0.4× 35 402
Kashif A. Haque United States 9 57 0.1× 44 0.6× 63 1.0× 7 0.1× 175 3.5× 15 522

Countries citing papers authored by Gabrielle E. Callander

Since Specialization
Citations

This map shows the geographic impact of Gabrielle E. Callander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabrielle E. Callander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabrielle E. Callander more than expected).

Fields of papers citing papers by Gabrielle E. Callander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabrielle E. Callander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabrielle E. Callander. The network helps show where Gabrielle E. Callander may publish in the future.

Co-authorship network of co-authors of Gabrielle E. Callander

This figure shows the co-authorship network connecting the top 25 collaborators of Gabrielle E. Callander. A scholar is included among the top collaborators of Gabrielle E. Callander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabrielle E. Callander. Gabrielle E. Callander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Jacobson, Laura H., Gabrielle E. Callander, & Daniël Hoyer. (2014). Suvorexant for the treatment of insomnia. Expert Review of Clinical Pharmacology. 7(6). 711–730. 43 indexed citations
2.
Callander, Gabrielle E., et al.. (2014). Development of human cells with RXFP1 knockdown using retroviral delivery of microRNA against human RXFP1. Italian Journal of Anatomy and Embryology. 118(1 Suppl). 10–12. 3 indexed citations
3.
Callander, Gabrielle E., Daniel Langenegger, Claudia Betschart, et al.. (2013). Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors. Frontiers in Neuroscience. 7. 230–230. 33 indexed citations
4.
Bathgate, Ross A. D., Michelle L. Halls, Emma T. van der Westhuizen, et al.. (2013). Relaxin Family Peptides and Their Receptors. Physiological Reviews. 93(1). 405–480. 405 indexed citations breakdown →
5.
Ganella, Despina E., Gabrielle E. Callander, Sherie Ma, et al.. (2012). Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus. Gene Therapy. 20(7). 703–716. 55 indexed citations
6.
Callander, Gabrielle E., Sherie Ma, Despina E. Ganella, et al.. (2012). Silencing Relaxin-3 in Nucleus Incertus of Adult Rodents: A Viral Vector-based Approach to Investigate Neuropeptide Function. PLoS ONE. 7(8). e42300–e42300. 19 indexed citations
7.
Callander, Gabrielle E. & Ross A. D. Bathgate. (2010). Relaxin family peptide systems and the central nervous system. Cellular and Molecular Life Sciences. 67(14). 2327–2341. 28 indexed citations
8.
Hartley, Brigham J., Daniel J. Scott, Gabrielle E. Callander, et al.. (2009). Resolving the Unconventional Mechanisms Underlying RXFP1 and RXFP2 Receptor Function. Annals of the New York Academy of Sciences. 1160(1). 67–73. 20 indexed citations
9.
Callander, Gabrielle E., Walter G. Thomas, & Ross A. D. Bathgate. (2009). Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of β-arrestin recruitment. American Journal of Physiology-Cell Physiology. 296(5). C1058–C1066. 41 indexed citations
10.
Callander, Gabrielle E., Walter G. Thomas, & Ross A. D. Bathgate. (2009). Development and Optimization of MicroRNA against Relaxin‐3. Annals of the New York Academy of Sciences. 1160(1). 261–264. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026